Literature DB >> 24440222

Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection.

Sudhir K Dutta1, Mohit Girotra2, Shashank Garg3, Anand Dutta4, Erik C von Rosenvinge5, Cynthia Maddox6, Yang Song6, John G Bartlett7, Rakesh Vinayek8, W Florian Fricke9.   

Abstract

The prevalence of recurrent Clostridium difficile infection (RCDI) is increasing; fecal microbiota transplantation (FMT) is an effective therapy. However, there have been no studies of the efficacy of a single session of combined enteral and colonic FMT or characterizations of changes in the microbiota between donors and recipients. We performed a study of 27 patients with RCDI who were given a fixed volume of processed fecal filtrate via enteroscopy and colonoscopy in a single session. Patients were closely monitored, and fecal samples were collected from 2 patient-donor pairs for 16S rRNA analysis. All patients had reduced stool frequency, abdominal pain, white blood cell counts, and elimination of fecal C difficile toxin (P < .05). FMT increased microbial diversity, increasing proportions of Lachnospiraceae (phylum Firmicutes) and reducing proportions of Enterobacteriaceae. FMT was associated with marked changes in the composition of fecal microbiota in 2 patients with RCDI.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  16s rRNA Analysis; Clostridium difficile; Colonic; FMT; Fecal Microbiota Transplantation; Jejunal; Lachnospiraceae; Microbiota; RCDI; Recurrent

Mesh:

Year:  2014        PMID: 24440222     DOI: 10.1016/j.cgh.2013.12.032

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  24 in total

1.  Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.

Authors:  Rohit Anand; Yang Song; Shashank Garg; Mohit Girotra; Amitasha Sinha; Anita Sivaraman; Laila Phillips; Sudhir K Dutta
Journal:  Dig Dis Sci       Date:  2017-02-08       Impact factor: 3.199

Review 2.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 3.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

Review 4.  Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.

Authors:  Fawziah Marra; Karen Ng
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

Review 5.  Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.

Authors:  Colleen R Kelly; Stacy Kahn; Purna Kashyap; Loren Laine; David Rubin; Ashish Atreja; Thomas Moore; Gary Wu
Journal:  Gastroenterology       Date:  2015-05-15       Impact factor: 22.682

Review 6.  Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications.

Authors:  Alejandra de Moreno de LeBlanc; Jean Guy LeBlanc
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

7.  Editorial: Making Fecal Microbiota Transplantation Easier to Swallow: Freeze-Dried Preparation for Recurrent Clostridium difficile Infections.

Authors:  Ilan Youngster; Dale N Gerding
Journal:  Am J Gastroenterol       Date:  2017-06       Impact factor: 10.864

8.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.

Authors:  Mohit Girotra; Shashank Garg; Rohit Anand; Yang Song; Sudhir K Dutta
Journal:  Dig Dis Sci       Date:  2016-07-22       Impact factor: 3.199

Review 9.  Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.

Authors:  Caná L Ross; Jennifer K Spinler; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-12       Impact factor: 3.331

Review 10.  Fecal microbiota transplantation for the treatment of Clostridium difficile infection.

Authors:  Krishna Rao; Nasia Safdar
Journal:  J Hosp Med       Date:  2015-09-07       Impact factor: 2.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.